Phase I trial of the anti-idiotypic monoclonal antibody (mAb) ACA-125 in patients with epithelial ovarian, fallopian tube or primary peritoneal cancer.

被引：0
|
作者：
Sabbatini, P
Aghajanian, C
Dupont, J
Derosa, F
Anderson, S
McGuire, W
Rodabaugh, K
Ferrone, S
Lele, S
Odunsi, K
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Franklin Sq Hosp, Baltimore, MD USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5018
引用
收藏
页码：453S / 453S
页数：1
相关论文
共 50 条
  • [1] Phase I/II trial of the anti-idiotypic monoclonal antibody ACA125 in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer.
    Hilpert, F
    Harter, P
    Reinartz, S
    Sehouli, J
    Loibl, S
    Canzler, U
    Belau, A
    Reuss, A
    Jackisch, C
    Pfisterer, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 459S - 459S
  • [2] Immunotherapy in patients with recurrent epithelial ovarian cancer with the anti-idiotypic monoclonal antibody ACA125 (AGO-OVAR, Phase I/II trial)
    Kimmig, R.
    Belau, A.
    Jackisch, C.
    Reinartz, S.
    Wollschlaeger, K.
    Hellmann, V.
    Harter, P.
    Hilpert, F.
    Reuss, A.
    Pfisterer, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 269 - 269
  • [3] Immunotherapy of advanced ovarian cancer with the anti-idiotypic antibody MAb ACA 125 - Results of a clinical phase IB study
    Wagner, U
    Kohler, S
    Giffels, P
    Schmolling, J
    Reinartz, S
    Krebs, D
    Schlebusch, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 527 - 527
  • [4] The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR
    Pfisterer, J.
    du Bois, A.
    Sehouli, J.
    Loibl, S.
    Reinartz, S.
    Reuss, A.
    Canzler, U.
    Belau, A.
    Jackisch, C.
    Kimmig, R.
    Wollschlaeger, K.
    Heilmann, V.
    Hilpert, F.
    ANNALS OF ONCOLOGY, 2006, 17 (10) : 1568 - 1577
  • [5] Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Sabbatini, Paul
    Dupont, Jakob
    Aghajanian, Carol
    Derosa, Felicia
    Poynor, Elizabeth
    Anderson, Sybil
    Hensley, Martee
    Livingston, Phillip
    Lasonos, Alexia
    Spriggs, David
    McGuire, William
    Reinartz, Silke
    Schneider, Sally
    Grande, Cathy
    Lele, Shashikant
    Rodabaugh, Kerry
    Kepner, James
    Ferrone, Soldano
    Odunsi, Kunle
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5503 - 5510
  • [6] CA125 mimicry by SCFV-fragments of the monoclonal anti-idiotypic antibody ACA125 for immunotherapy of ovarian cancer
    Reinartz, S
    Schlebusch, H
    Giffels, P
    Kohler, S
    Krebs, D
    Wagner, U
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 549 - 549
  • [7] Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer - Reply
    Sabbatini, Paul
    Odunsi, Kunle
    CLINICAL CANCER RESEARCH, 2007, 13 (13) : 4026 - 4027
  • [8] Immunological responses to CA125 induced by the anti-idiotypic antibody MAb ACA125 - Results or a clinical phase Ib study
    Wagner, U
    Kohler, S
    Schmolling, J
    Reinartz, S
    Schlebusch, H
    Krebs, D
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 102 - 102
  • [9] Phase II trial of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Hagemann, Andrea R.
    Zighelboim, Israel
    Novetsky, Akiva Pesach
    Gao, Feng
    Massad, L. Stewart
    Thaker, Premal H.
    Powell, Matthew A.
    Mutch, David Gardner
    Wright, Jason D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer.
    Landen, Charles N.
    Buckanovich, Ronald J.
    Sill, Michael
    Mannel, Robert S.
    Walker, Joan L.
    Disilvestro, Paul
    Mathews, Cara Amanda
    Mutch, David Gardner
    Hernandez, Marcia
    Martin, Lainie P.
    Bishop, Erin
    Gill, Sarah
    Gordinier, Mary E.
    Burger, Robert Allen
    Aghajanian, Carol
    Liu, Joyce F.
    Moore, Kathleen N.
    Bookman, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345